Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
作者： Oriol Casanovas , Daniel J. Hicklin , Gabriele Bergers , Douglas Hanahan
DOI: 10.1016/J.CCR.2005.09.005
关键词:
摘要: … tumors grew during this period (Figure 3B and data not shown). The data indicate that, during this short time … -VEGFR2 signaling circuit is an increasingly validated target in solid tumors, …
core.ac.uk
elsevier.com
researchgate.net 
sci-hub.se 参考文章(46)
Christopher J. Sweeney, George W. Sledge, Kathy D. Miller, Can tumor angiogenesis be inhibited without resistance? Mechanisms of Angiogenesis. pp. 95- 112 ,(2005) , 10.1007/3-7643-7311-3_7
R. Pili, A. Passaniti, G. R. Martin, D. S. Grant, R. M. Taylor, P. V. Long, Y. Guo, R. R. Pauly, J. A. Haney, A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Laboratory Investigation. ,vol. 67, pp. 519- 528 ,(1992)
Robert S. Kerbel, Joanne Yu, Jennifer Tran, Shan Man, Alicia Viloria-Petit, Giannoula Klement, Brenda L. Coomber, Janusz Rak, Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer and Metastasis Reviews. ,vol. 20, pp. 79- 86 ,(2001) , 10.1023/A:1013172910858
Francesco Pezzella, Ugo Pastorino, Elda Tagliabue, Salvatore Andreola, Gabriella Sozzi, Giampietro Gasparini, Sylvie Menard, Kevin C Gatter, Adrian L Harris, Steve Fox, Marc Buyse, Silvana Pilotti, Marco Pierotti, Franco Rilke, None, Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis American Journal of Pathology. ,vol. 151, pp. 1417- 1423 ,(1997)
Gabriele Bergers, Rolf Brekken, Gerald McMahon, Thiennu H. Vu, Takeshi Itoh, Kazuhiko Tamaki, Kazuhiko Tanzawa, Philip Thorpe, Shigeyoshi Itohara, Zena Werb, Douglas Hanahan, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology. ,vol. 2, pp. 737- 744 ,(2000) , 10.1038/35036374
Amelia Compagni, Maria-Antonietta Impagnatiello, Matt Cotten, Petra Wilgenbus, Gerhard Christofori, Fibroblast Growth Factors Are Required for Efficient Tumor Angiogenesis Cancer Research. ,vol. 60, pp. 7163- 7169 ,(2000)
Koichi Hattori, Beate Heissig, Yan Wu, Sergio Dias, Rafael Tejada, Barbara Ferris, Daniel J Hicklin, Zhenping Zhu, Peter Bohlen, Larry Witte, Jan Hendrikx, Neil R Hackett, Ronald G Crystal, Malcolm AS Moore, Zena Werb, David Lyden, Shahin Rafii, None, Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1 + stem cells from bone-marrow microenvironment Nature Medicine. ,vol. 8, pp. 841- 849 ,(2002) , 10.1038/NM740
Eduard Ryschich, Jan Schmidt, Günter J. Hämmerling, Ernst Klar, Ruth Ganss, Transformation of the microvascular system during multistage tumorigenesis. International Journal of Cancer. ,vol. 97, pp. 719- 725 ,(2002) , 10.1002/IJC.10074
Douglas Hanahan, Judah Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis Cell. ,vol. 86, pp. 353- 364 ,(1996) , 10.1016/S0092-8674(00)80108-7
Patricia S Steeg, Angiogenesis inhibitors: motivators of metastasis? Nature Medicine. ,vol. 9, pp. 822- 823 ,(2003) , 10.1038/NM0703-822